Table 1.

Patient Characteristics

Patient	Agent	Age/sex	Indication	Reaction	Reaction severitya	No. of desensitizations	Outcome
1	Rituximab	14/M	GLILD	5th exposure	Severe	4	Successful
2	Rituximab	7/M	PTLD	4th exposure	Moderate	3	Successful
3	Rituximab	23 months/F	OM	1st exposure	Moderate	10	Successful

Reexposure, reaction occurred after a previously tolerated course.

^aBrown classification criteria were used to classify reaction severity as mild, moderate, and severe.⁸

GLILD, granulomatous-lymphocytic interstitial lung disease; OM, opsoclonus myoclonus; PTLD, posttransplant lymphoproliferative disease.